Commerzbank Aktiengesellschaft Zoetis Inc. Transaction History

Commerzbank Aktiengesellschaft

$4.15 Billion
Q4 2024

A detailed history of Commerzbank Aktiengesellschaft transactions in Zoetis Inc. stock. As of the latest transaction made, Commerzbank Aktiengesellschaft holds 3,081 shares of ZTS stock, worth $507,286. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,081

Previous 2,590 18.96%

Holding current value

$507,286

Previous $507,000 1.38%

% of portfolio

0.01%

Previous 0.01%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 06, 2025	BUY	$162.24 - $194.42 $79,659 - $95,460	491 Added 18.96%	3,081 $500,000
Q3 2024 Oct 22, 2024	BUY	$172.58 - $196.48 $126,846 - $144,412	735 Added 39.62%	2,590 $507,000
Q2 2024 Jul 22, 2024	BUY	$145.54 - $178.83 $17,173 - $21,101	118 Added 6.79%	1,855 $322,000
Q1 2024 May 10, 2024	BUY	$165.67 - $199.94 $66,599 - $80,375	402 Added 30.11%	1,737 $294,000
Q4 2023 Sep 30, 2024	SELL	$151.44 - $200.09 $101,464 - $134,060	-670 Reduced 36.12%	1,185 $234,000
Q4 2023 Feb 01, 2024	BUY	$151.44 - $200.09 $202,172 - $267,120	1,335 New	1,335 $263,000
Q1 2022 May 02, 2022	SELL	$181.39 - $234.03 $283,875 - $366,256	-1,565 Closed	0 $0
Q4 2021 Oct 02, 2024	SELL	$193.69 - $247.03 $92,971 - $118,574	-480 Reduced 25.88%	1,375 $336,000
Q4 2021 Oct 01, 2024	SELL	$193.69 - $247.03 $92,971 - $118,574	-480 Reduced 25.88%	1,375 $336,000
Q4 2021 Jan 24, 2022	BUY	$193.69 - $247.03 $303,124 - $386,601	1,565 New	1,565 $382,000
Q3 2021 Oct 01, 2024	SELL	$189.29 - $209.69 $90,859 - $100,651	-480 Reduced 25.88%	1,375 $267,000
Q2 2020 Jul 21, 2020	SELL	$111.92 - $142.53 $201,903 - $257,124	-1,804 Closed	0 $0
Q1 2020 Apr 29, 2020	SELL	$92.66 - $144.94 $4.77 Million - $7.46 Million	-51,484 Reduced 96.61%	1,804 $212,000
Q4 2019 Oct 03, 2024	BUY	$116.25 - $133.25 $5.96 Million - $6.83 Million	51,283 Added 2764.58%	53,138 $7.03 Million
Q4 2019 Jan 17, 2020	BUY	$116.25 - $133.25 $919,653 - $1.05 Million	7,911 Added 17.43%	53,288 $7.05 Million
Q3 2019 Oct 03, 2024	BUY	$112.57 - $128.43 $4.88 Million - $5.57 Million	43,372 Added 2338.11%	45,227 $5.64 Million
Q3 2019 Oct 17, 2019	BUY	$112.57 - $128.43 $3.03 Million - $3.46 Million	26,923 Added 145.89%	45,377 $5.65 Million
Q2 2019 Oct 03, 2024	BUY	$97.98 - $114.28 $1.61 Million - $1.88 Million	16,449 Added 886.74%	18,304 $2.08 Million
Q2 2019 Jul 23, 2019	BUY	$97.98 - $114.28 $1.19 Million - $1.39 Million	12,140 Added 192.27%	18,454 $2.09 Million
Q1 2019 Oct 03, 2024	BUY	$81.56 - $100.67 $363,676 - $448,887	4,459 Added 240.38%	6,314 $636,000
Q1 2019 May 13, 2019	BUY	$81.56 - $100.67 $79,276 - $97,851	972 Added 18.2%	6,314 $636,000
Q4 2018 Oct 03, 2024	BUY	$79.28 - $95.27 $276,449 - $332,206	3,487 Added 187.98%	5,342 $457,000
Q4 2018 Feb 06, 2019	SELL	$79.28 - $95.27 $238,791 - $286,953	-3,012 Reduced 36.05%	5,342 $457,000
Q3 2018 Oct 04, 2024	BUY	$83.5 - $93.23 $542,666 - $605,901	6,499 Added 350.35%	8,354 $765,000
Q3 2018 Nov 13, 2018	SELL	$83.5 - $93.23 $310,369 - $346,535	-3,717 Reduced 30.79%	8,354 $765,000
Q2 2018 Oct 04, 2024	BUY	$79.9 - $89.2 $816,258 - $911,267	10,216 Added 550.73%	12,071 $1.03 Million
Q2 2018 Aug 10, 2018	BUY	$79.9 - $89.2 $28,364 - $31,666	355 Added 3.03%	12,071 $1.03 Million
Q1 2018 Oct 04, 2024	BUY	$71.51 - $84.69 $409,823 - $485,358	5,731 Added 95.76%	11,716 $978,000
Q1 2018 May 01, 2018	BUY	$71.51 - $84.69 $409,823 - $485,358	5,731 Added 95.76%	11,716 $978,000
Q4 2017 Oct 04, 2024	BUY	$63.24 - $72.8 $261,181 - $300,664	4,130 Added 222.64%	5,985 $431,000
Q4 2017 Jan 26, 2018	BUY	$63.24 - $72.8 $120,914 - $139,193	1,912 Added 46.94%	5,985 $431,000
Q3 2017 Nov 13, 2017	BUY	$59.73 - $65.4 $243,280 - $266,374	4,073	4,073 $260,000

Others Institutions Holding ZTS

# of Institutions

2,071

Shares Held

417M

Call Options Held

1.22M

Put Options Held

1.61M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $77.1B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Commerzbank Aktiengesellschaft , based on Form 13F filings with the SEC.

News

Stay updated on Commerzbank Aktiengesellschaft with notifications on news.

Account

Commerzbank Aktiengesellschaft Zoetis Inc. Transaction History